Trauma Stabilisation as a Sole Treatment Intervention

for Post-Traumatic Stress Disorder in Southeast Asia by Eichfeld, Cordula et al.
ORIG INAL PAPER
Trauma Stabilisation as a Sole Treatment Intervention
for Post-Traumatic Stress Disorder in Southeast Asia
Cordula Eichfeld, et al. [full author details at the end of the article]
# The Author(s) 2018
Abstract
Southeast Asia contains high numbers of traumatised populations arising from either natural
disasters or interpersonal violence. Consequently, the need for empirically based trauma
treatments, compromised by insufficiency in appropriately trained clinicians and mental health
workers, makes the situation more challenging in addressing traumatic sequelae in local
populations. In response, the humanitarian/ trauma capacity building organisation, Trauma
Aid Germany, trained 37 therapists in psycho-traumatology, based on EMDR Therapy, which
included trauma stabilisation techniques. This research analyses the impact of Trauma
Stabilisation as a sole treatment intervention for Post-Traumatic Stress Disorder (PTSD) in
adults. Each client was screened for PTSD utilising the Harvard Trauma Questionnaire - pre-
and post-treatment. Analysis of the data considered only those interventions focussed on
trauma stabilisation, including psychoeducation. Participants receiving trauma confrontation
interventions were excluded from the data. Trauma stabilisation - as a sole treatment interven-
tion, was highly effective in alleviating PTSD diagnoses. Results demonstrate PTSD symp-
toms were reduced in both clinical and sub-clinical trauma groups. The data set suggests
trauma stabilisation, as a sole treatment intervention, was safe, effective, efficient and sufficient
treatment intervention for PTSD. Furthermore, trauma stabilisation interventions have the
advantage of being safe, flexible, and adaptable to the cultural and spiritual context in which
they were are applied. The research findings also have implications regarding teaching and
learning and the potential utilisation of paraprofessionals, and other allied health professionals
in addressing the global burden of psychological trauma.
Keywords Post-traumatic stress disorder . Trauma stabilisation . Cultural sensitivity . Southeast
Asia . Therapeutic relationship . Trauma capacity building
Introduction
The Centre for Research on Epidemiology of Disasters (CRED) [1] reports, Asia as the
continent most affected by natural disasters (44.4%), has the most disaster victims (69.5%)
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and suffers the most damage (64.4% of worldwide natural disasters reported costs). An
example of this relates to the Indian Ocean Tsunami in Southeast Asia in December 2004.
This natural disaster was responsible for the death of 225,841 people making it the sixth
deadliest natural disaster in the world [2]. Post tsunami a survey by Souza et al. [3] carried out
in Aceh Province, Indonesia, determined that 83.6% of survivors demonstrated signs of
emotional distress and 77.1% depressive symptoms. Levels of emotional distress increased
the more individuals were exposed to tsunami-related deaths among household members.
Further post-tsunami studies highlight a prevalence of Posttraumatic Stress Disorder (PTSD) -
8.6 to 57.3% among Asian survivors of natural disasters. However, this was highly dependent
upon methodologies and diagnostic instruments used [2, 4].
Apart from natural disasters Southeast Asian populations suffers from various kinds of
interpersonal violence. The World Report on Violence and Health [5] defines violence as “The
intentional use of physical force or power, threatened or actual, against oneself, another person,
or against a group or community, that either results in or has a high likelihood of resulting in
injury, death, psychological harm, mal-development or deprivation” (p. 5). It further
distinguishes self-directed (inflicted upon person him−/herself), interpersonal (inflicted by
another individual/small group of individuals) and collective violence (inflicted by larger
groups such as organized political groups and terrorist organisation). Interpersonal violence
is divided into family and intimate partner violence (usually taking place in the home, also
called domestic violence) and community violence (violence between unrelated individuals,
generally taking place outside the home) [5].
An example of violence being perpetrated on an industrial scale relates to the acts of
genocide, perpetrated by the Khmer Rouge regime in Cambodia between 1975 and 1979.
Kiernan [6] estimates that this brutal regime was responsible for the deaths of between 1.67
and 1.87 million people – some 20% of the entire Cambodian population. The Khmer Rouge
were responsible for mass executions, persecution and perpetrating a regime of terror. As van
Schaack et al. [7] purports, the impact on mental health continues to be in evidence with regard
to PTSD, Depression and other severe mental health problems.
Availability of Therapists and Mental Health Services
At the same time, the education of the therapists in the region is quite poor and Mental Health
services are very rare. In Cambodia there are 63 mental health outpatient facilities resulting in a
rate of 0.42 per 100.000 people [8] and in Thailand 93 mental health outpatient facilities
resulting in a rate of 0.14 per 100.000 people [9]. For comparison, in Germany there are
24.881 mental health outpatient facilities resulting in a rate of 30.32 per 100.000 people [10].
For Indonesia there is no information available [11].
Trauma Aid and the Mekong I Project
Trauma Aid (HAP Germany) is a Humanitarian Organisation, which aims to establish Trauma
Capacity Building/ Psychotherapeutic services in crisis areas like Southeast Asia [12]. The
primary objective of the organisation is to train local health workers and non-governmental
organisations (NGOs), in psycho-traumatology, trauma interventions, and trauma self-care
based upon empirical research and international treatment guidelines [13–15]. Within the
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Trauma Aid Germany portfolio was the establishment of Mekong I [2010–2014] – a Trauma
Capacity Building Project for Thailand, Cambodia and Indonesia - Mekong I was funded by
the German Federal Ministry for Economic Cooperation and Development – also in co-
operation with Terre des Hommes (Germany). One of the primary objectives is to increase
the mental health – trauma capacity focussed on evidence-based treatment interventions. This
involved teaching and learning, skills training, diagnostic screening, and trauma treatment
interventions which included psychoeducation, stabilisation techniques and trauma processing
(confrontation) mainly centred upon Eye Movement Desensitization and Reprocessing
(EMDR) Therapy and empirically validated psychological treatment intervention for PTSD.
There were 37 therapists trained during Mekong I of which their professional background was
that they are either psychologists or psychiatrists.
Rationale for the Research
Herman [16] presented a model of trauma treatment that involves three critical phases:
Phase 1: Safety and Stabilisation
Phase 2: Remembering and Mourning
Phase 3: Reconnection
This three-phases approach is the recommended approach for treating PTSD, espe-
cially complex cases – as recommended by the current ISTSS guidelines for the
treatment of complex PTSD [17]. Phase 1 – Safety & Stabilisation, focuses on the
insurance of the individual’s safety, reducing symptoms and increasing emotional,
social and psychological competences. It also includes psychoeducation providing
explanations to account for client’s symptoms and experiences, giving the client hope
for resolution and providing, when appropriate, a sense of normalisation when neces-
sary. Phase 2 – Remembering & Mourning is ostensibly a ‘Trauma Confrontation’
phase, focuses on the processing of unresolved aspects of the individual’s memory of
the adverse life (traumatic) experience. WHO [18] empirically supports Trauma-
Focused Cognitive Behavior Therapy (TF-CBT) and EMDR therapy as efficacious
treatments for PTSD. Phase 3 – Re-connection, focuses on the consolidation of
change and moving forward [16, 19, 20]. There is evidence that the therapeutic
alliance and negative mood regulation achieved in Phase 1 predicts the success in
reducing PTSD in Phase 2 emphasising the value of establishing a strong therapeutic
relationship and emotion regulation skills before exposure work, especially among
chronic PTSD populations [21–23]. This fits with Asay and Lambert [24], Lambert
[25] who indicate that the therapeutic relationship accounts for 30% of client im-
provement (while specific techniques account for only 15%).
Stabilisation
The Mekong I project wanted to consider the impact of trauma stabilisation as a sole
treatment intervention in PTSD. Research supports the activation of the patients’
strength and resources as an important change mechanism in psychotherapy [26–28].
Especially with complex cases following childhood abuse, trauma-specific stabilisation
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has a prominent role. It includes techniques of attention focussing, the focussed use of
imaginative distancing techniques and the use of resource activating techniques [20,
29]. Techniques of attention refocusing direct the attention away from the traumatic
internal experience toward stimuli of the external (neutral or positive) reality resulting
in reduced distress. Imaginative distance techniques aim at reducing the traumatic
affect and enhancing the feeling of control and safety. Imagination techniques well
established are the “container” technique and the “safe place” exercise [20, 29, 30].
Resource activation is based on the principle that positive emotions can reduce the
impact of negative emotions [31]. Resources can be activated through imagination
evoking positive memories, personal successes, positive relationships and role models
[29, 32, 33].
The content of trauma stabilisation taught in the Mekong I training is included in
the treatment manual of Wöller and H. Mattheß [34] for Resource-oriented trauma
therapy combined with EMDR resource installation - ROTATE. ROTATE itself is not
a form of Trauma Stabilisation – but instead a manualisation of a multitude of
different trauma stabilisation techniques, strategies and interventions. The approach
aims at strengthening resilience and coping capacities by activating positive personal
resources within a secure therapeutic relationship. A variety of imaginative resource-
activating methods are included and based on a framework informed by affective
neuroscience, resilience research, and attachment theory. Despite containing EMDR
therapy elements and techniques, trauma stabilisation does not involve trauma con-
frontation or working with trauma memories. A RCT has shown that symptoms of
PTSD and other co-morbid trauma-related symptoms (like depression and anxiety) can
be effectively reduced using trauma stabilisation interventions as outlined in the
ROTATE manual and subsequent research study [35, 36].
There are distinct advantages to trauma stabilisation as a specific intervention - it
can be safely applied, is language-independent and flexible and thus culturally adapt-
able and especially suitable for clients in non-Western societies. One important aspect
for its use in the Mekong I Project is the ease in which knowledge transfer – training,
can take place. This enables broad dissemination in severely affected countries and the
treatment of a vast number of trauma survivors in a safe and effective way.
Lack of Research about Stabilisation
Even though Phase Orientated approaches and stabilisation techniques are commonly
used in therapeutic practise and recommended by the ISTSS guidelines for the
treatment of complex PTSD, there is still a lack of evidence, especially compared
to the numerous studies supporting evidence of TF-CBT and EMDR therapy. A group
of researchers and therapists even published a letter to the editor criticizing the current
ISTSS guideline that recommends the phase orientated approach [37]. They argue that
with the lack of evidence of the effectiveness of a preparation/stabilisation phase and
the effectiveness of stabilisation in general, only the evidence-based trauma focussed
approaches like TF-CBT and EMDR therapy should be recommended in the guideline
instead of a phase orientated approach.
The frequent use of trauma stabilisation techniques in the Mekong Project I, as this paper
will demonstrate, offers the opportunity to better understand the impact of this approach as a
distinct intervention, in an area where there is a scarcity of research data currently.
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Method
The Data of the Mekong I Project
Therapists and Data Collection of the Mekong I Project
During the Mekong I Project 37 therapists were trained - 9 from Cambodia, 12 Indonesia, 16
Thailand. The professional background of the trainees – 32 Psychologists and 5 Psychiatrists,
all of which had previous psychotherapy training. Of the 37 trainees – 21 Female, 16Male with
an age range of 29 to 62 years, and mean age of 39.48 years. All the therapists where trained on
a pro-bono basis. However, a condition was that they were expected to offer pro-bono treatment
back in their respective communities and collect clinical data about their clients. Data collection
also included psychometrics and diagnostic measures. Ethical approval for the study was
granted from the University of Worcester (UK) and was adopted in each the three countries.
The clients were service seekers that voluntarily participated in trauma treatment with each
informed about the possibility to withdraw their participation at any point – in accordance with
ethics approval guidelines. All in all, the demographic, diagnostic and treatment data of 4799
clients was documented and subsequently analysed. Data was first collected, via Microsoft Excel
Spread Sheet, in each country for the period of the research study – 3 years, before being put
together into a collective data set ready for retrospective analysis using post inclusion criteria.
Data of Clients of the Mekong I Project
The centralised Microsoft Excel sheet was transferred into SPSS version 24. The recorded data
of the 37 therapists had to be further structured and partly recorded to create a coherent data
file. The result is that this large data set contained over 2000 variables of the 4799 clients who
took part in the study. The profiles were as follows:
Indonesia (n = 2363, 49.2%), Cambodia (n = 1483, 30.9%), Thailand (n = 953, 19.9%)
Type of Client: Adults (n = 2561, 53.4%), Children/adolescents (n = 2238, 46.6%)
Female (n = 2709, 56.4%), Male clients (n = 2057, 42.9%), Transsexual (n = 33, 0.7%)
Preparation of the Data
Most of the data collected is mainly quantitative, however some qualitative material was also
captured. About 30% of the qualitative data was documented using indigenous language of the
respective therapists and then translated by local linguistic experts into English. The qualitative
data was analysed using a program for semantic analysis by Braun and Clarke [38]. However
only the quantitative date will be presented in this paper.
Analysis for this Article
The Included Data -Inclusion Criteria and Description of Clients and Therapies
This article will only present the research findings from the adult client group who received
trauma stabilisation interventions only. For the study, Trauma Stabilisation is defined as
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including resource interventions, grounding techniques, comprehensive history taking, trauma
preparation, trauma mapping, trauma case conceptualisation and psychoeducation. For each
client each therapist wrote a treatment outline containing the number of sessions, setting and
duration of each session and indicated the specific stabilisation/confrontation interventions
used each session. Only clients were included in the analysis who had received no trauma
confrontation intervention at all and at least one intervention of trauma stabilisation. Treatment
fidelity was ensured through active clinical supervision and through supervised self-experience
teaching and learning sessions. Using this inclusion criteria data was analysed from n = 1358
clients. For detailed demographic information please view Table 1. The mean amount of
sessions, for the included data, was 4.31 (SD 3.24, range 1 to 23). The mean number of
Trauma Stabilisation interventions used was 7.23 (SD 5.50, range 1 to 64).
Diagnostic Measures
Two specific psychometrics were used. For assessing the PTSD diagnosis, the Harvard Trauma
Questionnaire (HTQ - 40 items), and the Hopkins Symptoms Checklist Questionnaire (HSCL-
25 items) to assess Anxiety and Depression – pre- and post-treatment. Both scales were
Table 1 Demographic information and number of sessions/trauma stabilisation techniques for the clients of the
whole data set and respectively for all steps of inclusion
Characteristics Inclusion criteria for analysis
Mekong
data
only adults,
stabilisation
Pre- &
post-
measures
HTQ diagnosis
pre-treatment
DSM-V
PTSD
ICD-11
PTSD
N 4799
(100%)
1358 (100%) 365 (100%) 197 (100%) 164 (100%)
Country
Cambodia 1483
(30.9%)
654 (48.2%) 206
(56.4%)
128 (65.0%) 98 (59.8%)
Indonesia 2363
(49.2%)
414 (30.5%) 78 (21.4%) 46 (23.4%) 46 (28.0%)
Thailand 953
(19.9%)
290 (21.4%) 81 (22.2%) 23 (11.7%) 20 (12.2%)
Client group
Adults 2561
(53.4%)
1358 (100%) 365 (100%) 197 (100%) 164 (100%)
Children/Adolescents 2238
(46.6%)
– – – –
Gender
Male 2057
(42.9%)
468 (34.5%) 103
(28.2%)
46 (23.4%) 37 (22.6%)
Female 2709
(56.4%)
885 (65.2%) 258
(70.7%)
147 (74.6%) 124
(75.6%)
Transgender 33 (0.7%) 5 (0.4%) 4 (1.1%) 4 (2.0%) 3 (1.8%)
Age (Mean (SD)) 23.39
(12.27)
31.69 (12.02) 34.52
(11.81)
36.76
(11.01)
36.93
(11.07)
Therapies
Mean N Sessions (SD) 5.4 (4.7) 4.3 (3.2) 6.7 (3.9) 7.7 (3.9) 7.6 (3.8)
Mean N stabilisation
techniques (SD)
9.5 (10.1) 7.2 (5.5) 11.0 (6.6) 10.5 (7.1) 10.0 (6.9)
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deliberately chosen as they have international application and validation and were subsequent-
ly available in language versions in Indonesian, Khmer and Thai. Therapists were trained and
data evaluated strictly according to the manual “Measuring Trauma Measuring Torture” of the
Harvard Program in Refugee Trauma [39]. Internal consistency (Cronbach’s α) at baseline of
the HTQ and HSCL-25 in our sample was 0.96 and 0.94, respectively.
Description of Reported Results
The publication focuses on PTSD diagnosis in adult populations in Indonesia, Cambodia and
Thailand however, further outcomes will be reported in future publications.
For the clients, the following results can be reported:
Remission rates: the PTSD scale of the HTQ includes items reflecting the DSM-V and the
forthcoming ICD-11 criteria for PTSD. A study investigating the impact of the changes to
diagnostic criteria for PTSD in DSM-Vand the proposed changes in ICD-11 found that while
there is an overlap of the PTSD diagnoses, each identified a proportion of people with PTSD
which the other system did not [40]. As different study populations are defined depending on
the diagnostic classification system used, the comparison between studies using different
diagnosis systems is hindered. To prevent this, for the analysis DSM-V as well as ICD-11
PTSD is reported. PTSD status was calculated using the item mapping for the DSM-V and
ICD-11 models of PTSD as suggested by Hyland [41]. Criterion A (traumatic stressor) was
established with a detailed list of Traumatic Events. PTSD is diagnosed via DSM-V criteria
when a client scores 3 or 4 in (i) at least one of the four intrusion symptoms (criterionB), (ii) at
least one of the two avoidance symptoms (criterionC), (iii) at least two of the seven symptoms
regarding negative alternations in cognitions and mood (abbreviation Neg.Alt. Cogn&Mood,
criterion D), and (iv) at least two of the five arousal symptoms (criterion E). PTSD is
diagnosed via the purposed ICD-11 criteria when a client scores 3 or 4 in (i) at least one of
the two re-experiencing symptoms, (ii) at least one of the two sense of threat symptoms and
(iii) at least one of the two avoidance symptoms. Patients no longer fulling these criteria of
DSM-V/ICD-11 PTSD after treatment are regarded as remitted.
Additionally to Remission rates, the Treatment Effect can also be reported. The treatment
effect is calculated as the reduction of fulfilled PTSD diagnoses and the syndrome reduction
due to Trauma Stabilisation interventions. Only clients were included in the analysis, where
pre- and post-measures of the HTQ were available, 365 clients meet this criterion.
Inclusion Criterium Fulfilment of PTSD Diagnosis
Pre-treatment 197 (54.0%) of the included 365 clients fulfilled the diagnosis of PTSD via DSM-
V criteria and 164 (44.9%) via ICD-11 criteria. For the following analysis, only clients fulfilling
the respective diagnosis pre-treatment (DSM-V/ICD-11 PTSD) are included. In a later section,
the results for all included clients regardless their PTSD diagnosis pre-treatment are reported.
Statistical Analysis
All data was analysed using SPSS version 24. The pairwise comparisons of the binary
variables (remission rates of PTSD diagnoses and PTSD criteria) were calculated via
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McNemar tests. The pairwise comparisons of the number of criteria fulfilled of the respective
PTSD diagnoses and of the number of symptoms of the respective DSM-V/ICD-11 criteria
were calculated via dependent t-tests. From the t-tests the effect sizes r and Hedges’s gav were
calculated. As Cohen’s dz is argued to be an overestimation of the effect size of correlated
samples and Cohen’s dav is positively biased, Hedges’s corrected and recommended Hedges’s
gav is reported [42, 43]. The a-level was Bonferroni adjusted for multiple comparisons (a =
0.0028 = 0.05/18; PTSD DSM-Vand ICD-11 remission, Number of criteria of DSM-Vand of
ICD-11 PTSD, criteria of PTSD (DSM-V: Intrusions, Neg.Alt. Cogn&Mood, Arousal, Avoid-
ance, ICD-11: Re-experiencing, Sense of threat, Avoidance), Number of symptoms of the five
DSM-V and the four ICD-11 PTSD criteria).
Results
PTSD remission rates were 91.4% for DSM-Vand 93.3% for ICD-11 diagnosis as highlighted
in Fig. 1. McNemar tests determined that there was a significant difference of the proportion of
clients with PTSD diagnosis pre- and post-treatment, (p < 0.00001 for both DSM-Vand ICD-11
PTSD), for further details please view Table 2. On average, clients fulfilled less DSM-V PTSD
criteria after the trauma stabilisation treatment (M = 1.97, SD = 1.387) than before treatment
(M = 5.0, SD = 0.00). This difference, 3.025, BCa 95% CI [2.831, 3.220] was significant
t(196) = 30.623, p < 0.001, and represented a large-sized effect, r = 0.910 and Hedges’s gav =
3.078, BCa 95% CI [2.875, 3.271]. The CL effect size indicates that after controlling for
individual differences, the likelihood that a person scores higher pre-treatment than after
treatment is 98.6%. On average, clients fulfilled less ICD-11 PTSD criteria after treatment
(M = 1.54, SD = 0.92) than before treatment (M = 4.0, SE = 0.00). This difference, 2.457, BCa
95% CI [2.316, 2.599] was significant t(163) = 34.363, p < 0.001, and represented a large-sized
effect, r = 0.937 and Hedges’s g av = 3.780, BCa 95% CI [3.559, 3.994]. The CL effect size
Fig. 1 PTSD Remission after trauma stabilisation treatment: Number of clients fulfilling DSM-V/ICD-11 PTSD
prior treatment (blue/black bars) and Number of clients still fulfilling DSM-V/ICD-11 PTSD after treatment
(orange/ grey bars)
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indicates that after controlling for individual differences, the likelihood that a person scores
higher pre-treatment than after treatment is 99.6%. These results are also highlighted in Table 3.
Remission rates for DSM-V PTSD and ICD-11 PTSD criteria ranged between 72.1 and
86.0%. McNemar tests determined that there were significant differences of the proportion of
clients with PTSD criteria pre- and post-treatment, (p < 0.00001 for both DSM-V and ICD-11
PTSD criteria), for further details please view Table 4. On average, clients fulfilled less
symptoms of the respective DSM-V PTSD criteria after treatment than before treatment. These
differences were significant (p < 0.001 for all symptom criteria) and represented large-sized
effects (r between 0.865 and 0.914 and Hedges’s g av between 2.50 and 3.09), for further
details please view Table 5. The CL effect sizes indicate that after controlling for individual
differences, the likelihood that a person scores higher pre-treatment than after treatment in
symptoms of DSM-V PTSD intrusions is 95.8%, in symptoms of DSM-V PTSD Neg. Alt.
Cogn&Mood 97.8%, in symptoms of DSM-V PTSD Arousal 98.8%. and in symptoms of
DSM-V PTSD Avoidance 97.9%. On average, clients fulfilled less symptoms of the respective
ICD-11 PTSD criteria after treatment than before treatment. These differences were significant
(p < 0.001 for all symptom criteria) and represented large-sized effects (r between 0.892 and
0.910 and Hedges’s g av between 2.88 and 3.25). The CL effect sizes indicate that after
controlling for individual differences, the likelihood that a person scores higher pre-treatment
than after treatment in symptoms of ICD-11 PTSD re-experiencing is 98.5%, in symptoms of
ICD-11 PTSD Sense of threat 97.6% and in symptoms of ICD-11 PTSD Avoidance 98.6%.
Results for the Entire Range of PTS Problems
Additionally to the treatment effect of clients with DSM-V/ICD-11 PTSD pre-treatment, the
treatment effect for subclinical clients and ‘normal’ scoring clients can be reported. In this section,
the analysis of all included clients (365 clients) regardless of their diagnosis before treatment is
reported. The distribution of fulfilled PTSD criteria pre- and post-treatment is shown in Figs. 2 and 3.
Table 2 Remission of (respective DSM-V/ICD-11) PTSD diagnosis after trauma stabilisation treatment
HTQ Number of participants Remission rate McNemar test
Pre-treatment Post-treatment Test statistica p
DSM-V PTSD 197 (100%) 17 (8.6%) 91.4% 178.006 < 0.00001
ICD-11 PTSD 164 (100%) 11 (6.7%) 93.3% 151.007 < 0.00001
a Chi-Square, continuity corrected
Table 3 Remission of PTSD criteria after trauma stabilisation treatment: Pairwise comparisons of the mean
number of fulfilled criteria for DSM-V/ICD-11 PTSD before and after the trauma stabilisation treatment for
clients fulfilling DSM-V/ICD-11 PTSD pre-treatment
HTQ Raw mean (standard deviation) t Bootstrap p Hedges’s g ava [BCa 95% CI] r
Nr. Of criteria Pre-treatment Post-treatment
DSM-V PTSDb 5.00 (0.0) 1.97 (1.387) 30.623 < 0.001 3.08 [2.88, 3.27] 0.910
ICD-11 PTSDc 4.00 (0.0) 1.54 (0.916) 34.363 < 0.001 3.78 [3.56, 3.99] 0.937
a Hedges’s g av is used as a corrected effect size to the biased Cohen’s dav, b 0–5 criteria of DSM-V PTSD
possible, c 0–4 criteria of ICD-11 PTSD possible
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Six clients (1.6%) did not fulfil any criteria of DSM-V PTSD. For 83.3% this didn’t change
after treatment, 1 client was subclinical after treatment (fulfilling three criteria of DSM-V
PTSD). 162 clients (44.4%) were subclinical prior treatment fulfilling one (28 clients), two (38
clients), three (38 clients) or four (58 clients) DSM-V PTSD criteria prior treatment. For this
subclinical client group 12 clients remised (no criteria of DSM-V PTSD after treatment), 104
clients (64.2%) improved, but stayed subclinical, 7 clients (4.3%) deteriorated, but remained
subclinical and 5 clients (3.1%) were diagnosed with DSM-V PTSD still after treatment.
6 clients (1.6%) did not fulfil any criteria of ICD-11 PTSD pre-treatment. For all 6 clients,
this didn’t change after treatment. 195 clients (53.2%) were subclinical prior treatment fulfilling
one (59 clients), two (54 clients) or three (82 clients) ICD-11 PTSD criteria prior treatment. For
Table 4 Remission of DSM-V and of ICD-11 PTSD criteria after the trauma stabilisation treatment for clients
fulfilling DSM-V/ICD-11 PTSD pre-treatment
HTQ Number of participants Remission rate McNemar test
Pre-treatment Post-treatment Test statistica p
DSM-V PTSDb
Intrusions 197 (100%) 50 (25.4%) 74.6% 145.007 < 0.00001
Neg.Alt. cogn.&mood 197 (100%) 46 (23.4%) 76.6% 149.007 < 0.00001
Arousal 197 (100%) 55 (27.9%) 72.1% 140.007 < 0.00001
Avoidance 197 (100%) 41 (20.8%) 79.2% 154.006 < 0.00001
ICD-11 PTSDb
Re-experiencing 164 (100%) 23 (14.0%) 86.0% 139.007 < 0.00001
Sense of threat 164 (100%) 34 (20.7%) 79.3% 128.008 < 0.00001
Avoidance 164 (100%) 32 (19.5%) 80.5% 130.008 < 0.00001
a Chi-Square, continuity corrected
b except criterion A where no remission is possible
Table 5 Remission from PTSD symptoms after trauma stabilisation treatment: Pairwise comparisons of the
mean number of fulfilled symptoms of the respective criterium for DSM-V/ICD-11 PTSD pre- and post-
treatment for clients fulfilling DSM-V/ICD-11 PTSD pre-treatment
HTQ Raw mean (standard deviation) t Bootstrap p Hedges’s g ava
[BCa 95% CI]
r
Nr. Of symptoms Pre-treatment Post-treatment
DSM-V PTSD
Intrusionsb 3.06 (1.041) 0.50 (1.003) 24.171 < 0.001 2.50 [2.30, 2.68] 0.865
Neg.Alt. cogn.&moodc 5.17 (1.575) 0.86 (1.515) 28.285 < 0.001 2.78 [2.58, 3.00] 0.896
Arousald 4.335 (0.886) 0.93 (1.272) 31.568 < 0.001 3.09 [2.91, 3.28] 0.914
Avoidancee 1.79 (0.407) 0.28 (0.598) 28.607 < 0.001 2.94 [2.75, 3.11] 0.900
ICD-11 PTSD
Re-experiencingf 1.59 (0.493) 0.18 (0.469) 27.683 < 0.001 2.92 [2.72, 3.13] 0.908
Sense of threatf 1.77 (0.423) 0.28 (0.592) 25.228 < 0.001 2.88 [2.67, 3.09] 0.892
Avoidancee 1.84 (0.372) 0.26 (0.574) 28.044 < 0.001 3.25 [3.00, 3.48] 0.910
a Hedges’s g av is a corrected effect size to the biased Cohen’s dav
b 0–4 symptoms of DSM-V PTSD Intrusions possible
c 0–8 symptoms of DSM-V PTSD Neg.Alt. Cogn&Mood possible
d 0–5 symptoms of DSM-V PTSD Arousal possible
e 0–2 symptoms of DSM-V/ICD-11 PTSD Avoidance possible
f 0–2 symptoms of ICD-11 PTSD Re-experiencing/Sense of threat possible
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Fig. 2 Distribution of clients fulfilling DSM-V PTSD (black/red), partly fulfilling PTSD (1 up to 4 of 5 DSM-V
PTSD criteria fulfilled, 4 ranges of grey/orange, lighter colours represent-ing less criteria), no PTSD (white/
green) before and after trauma stabilisation treatment
Fig. 3 Distribution of clients fulfilling ICD-11 PTSD (red/dark grey), partly fulfilling PTSD (1 (orange/grey) or 2
(yellow/light grey) of 3 ICD-11 PTSD criteria fulfilled), no PTSD (green/white) before and after trauma
stabilisation treatment
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this subclinical client group 13 clients remised (no criteria of ICD-11 PTSD after treatment), 93
clients (47.7%) improved, but stayed subclinical, 9 clients (4.6%) deteriorated, but remained
subclinical and 10 clients (5.1%) were diagnosed with ICD-11 PTSD after treatment.
With 5 clients developing DSM-V PTSD and 10 clients developing ICD-11 PTSD during
the time of the treatment, the analysed treatment effect might change, if the whole client group
(no, subclinical, clinical PTSD) is included. Thus, all analyses were calculated once more with
all clients regardless their diagnoses pre-treatment (N = 365 clients). The proportion of clients
with and without PTSD before and after treatment is highlighted in Figs. 4 and 5.
McNemar tests determined that there was a significant difference of the proportion of
clients with PTSD diagnosis pre- and post-treatment, (p < 0.00001 for both DSM-V and ICD-
11 PTSD). The odd of remission of DSM-V PTSD is 36 times greater than the risk of getting
the DSM-V PTSD diagnoses after treatment. The odd of remission of ICD-11 PTSD is 15.3
times greater than the risk of getting the ICD-11 PTSD diagnoses after treatment. For further
details please view Table 6. On average, clients fulfilled less DSM-V PTSD criteria after
treatment (M = 1.72, SD = 1.299) than before treatment (M = 3.93, SD = 1.419). This differ-
ence, 2.214, BCa 95% CI [2.046, 2.384] was significant t(364) = 25.474, p < 0.001, and
represented a large-sized effect, r = 0.800 and Hedges’s g av = 1.621, BCa 95% CI [1.499,
1.750]. The CL effect size indicates that after controlling for individual differences, the
likelihood that a person scores higher pre-treatment than after treatment is 90.8%. On average,
clients fulfilled less ICD-11 PTSD criteria after treatment (M = 1.45, SD = 0.93) than before
treatment (M = 2.93, SD = 1.18). This difference, 1.48, BCa 95% CI [1.354, 1.611] was
significant t(365) = 20.948, p < 0.001, and represented a large-sized effect, r = 0.739 and
Hedges’s g av = 1.391, BCa 95% CI [1.273, 1.515]. The CL effect size indicates that after
controlling for individual differences, the likelihood that a person scores higher pre-treatment
than after treatment is 86.3%. These results are also shown in Table 7.
On average, clients fulfilled less symptoms of the respective DSM-V PTSD criteria after
treatment than before treatment. These differences were significant (p < 0.00001 for all symptom
criteria) and represented large-sized effects (r between 0.672 and 0.789 andHedges’s g av between
Figs 4 and 5 Proportion of clients with PTSD (red/black) and without PTSD (green/grey) diagnoses before and
after trauma stabilisation for DSM-V and ICD-11 PTSD respectively
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1.25 and 1.63). The CL effect sizes indicate that after controlling for individual differences, the
likelihood that a person scores higher pre-treatment than after treatment in symptoms of DSM-V
PTSD intrusions is 87.1%, in symptoms of DSM-V PTSD Neg.Alt. Cogn&Mood 86.2%, in
symptoms of DSM-V PTSD Arousal 90.0%. and in symptoms of DSM-V PTSD Avoidance
81.9%. On average, clients fulfilled less symptoms of the respective ICD-11 PTSD criteria after
treatment than before treatment. These differences were significant (p < 0.001 for all symptom
criteria) and represented large-sized effects (r between 0.672 and 0.789 andHedges’s g av between
1.25 and 1.63). The CL effect sizes indicate that after controlling for individual differences, the
likelihood that a person scores higher pre-treatment than after treatment in symptoms of ICD-11
PTSD re-experiencing is 78.4%, in symptoms of ICD-11 PTSD Sense of threat 83.8%. and in
symptoms of DSM-V PTSD Avoidance 81.8%. For detailed results please see Tables 8 and 9.
The remission of PTSD criteria after treatment is highlighted in Figs. 6 and 7.
Comparison to Control Group
To put the extremely high effect sizes in relation, the treatment effect was compared to a
control group from a previously published study [35, 36] and aggregated. This was possible
Table 6 Remission of PTSD diagnosis after trauma stabilisation treatment: Pairwise comparisons of PTSD
diagnosis (via DSM-Vand ICD-11 respectively) before and after trauma stabilisation treatment for all 365 clients
HTQ Number of participants McNemar OR remission/ risk
Pre-treatment Post-treatment Test statistica p
DSM-V PTSD 197 (54.0%) 22 (6.0%) 163.654 < 0.00001 36
ICD-11 PTSD 164 (44.9%) 21 (5.8%) 123.706 < 0.00001 15.3
a Chi-Square, continuity corrected
Fig. 4 and 5 (continued)
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because it involved the same therapists from the Mekong I Project and included the same
diagnostic tools and psychometrics. This made for a suitable comparison. The control group
consisted of 55 clients (38 female clients, mean age 25.64 (SD 9.425)) who were waiting
5 weeks between their first and second diagnostic assessment.
Figs 6 and 7 Remission of PTSD criteria after trauma stabilisation treatment: Number of participants fulfilling
DSM-V/ICD-11 PTSD criteria prior treatment (blue/black bars) and after treatment (orange/ grey bars)
Fig. 6 and 7 (continued)
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45 clients (81.8%) of the control group fulfilled the criteria for DSM-V PTSD before waiting.
The remission rate was 24.4% (vs. 91.4% remission rate for stabilisation treatment group). On
average, clients fulfilled less DSM-V PTSD criteria after waiting (M = 4.38, SD = 1.451) than
before treatment (M = 5.0, SE = 0.00). This difference, 0.622, BCa 95% CI [0.282, 1.057] was
significant t(44) = 2.878, p = 0.025, and represented a medium-sized effect, r = 0.398 and
Hedges’s g av = 0.594, BCa 95% CI [0.270, 1.013]. The odd of remission of DSM-V PTSD is
2.2 times greater than the risk of getting the DSM-V PTSD diagnoses after waiting. 33 clients
(60.0%) of the control group fulfilled the criteria for ICD-11 PTSD before waiting. The remis-
sion rate was 33.3% for the control group (vs. 93.3% remission rate for stabilisation treatment
group). On average, clients fulfilled less ICD-11 PTSD criteria after waiting (M = 3.33, SD =
Table 7 Remission of PTSD criteria after trauma stabilisation treatment: Pairwise comparisons of the mean
number of fulfilled DSM-V/ICD-11 PTSD criteria before and after trauma stabilisation treatment for all 365
clients
HTQ Raw mean (standard deviation) t p Hedges’s g ava
[95% CI]
r
Nr. Of criteria Pre-treatment Post-treatment
DSM-V PTSDb 3.93 (1.419) 1.72 (1.299) 25.474 < 0.001 1.62 [1.50, 1.75] 0.800
ICD-11 PTSDc 2.93 (1.179) 1.45 (0.929) 20.948 < 0.001 1.39 [1.27, 1.51] 0.739
a Hedges’s g av is used as a corrected effect size to the biased Cohen’s dav
b 0–5 criteria of DSM-V PTSD possible
c 0–3 criteria of ICD-11 PTSD possible
Figs 8 and 9 Remission of the five DSM-V PTSD criteria and of the four ICD-11 PTSD criteria for the trauma
stabilisation treatment group (orange/grey line) and for the waiting-list control group (blue/black line)
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1.216) than before treatment (M = 4.0, SE = 0.00). This difference, 0.667, BCa 95% CI [0.321,
1.081] was significant t(32) = 3.149, p = 0.025, and represented a medium-sized effect, r = 0.486
and Hedges’s g av = 0.761, BCa 95%CI [0.365, 1.228]. The odd of remission of ICD-11 PTSD is
1.38 times greater than the risk of getting the ICD-11 PTSD diagnoses after waiting.
General linear model analyses were conducted to analyse differences in the PTSD remis-
sion between the two groups. There was a significant effect of the group, indicating that the
remission of DSM-V PTSD criteria differs between stabilisation treatment and control group,
F(1, 240) = 108.156, p < 0.00001, r = 0.557, ηp2 = 0.311. This indicates that 31.03% of the
Fig. 8 and 9 (continued)
Table 8 Pairwise comparisons of DSM-V and ICD-11 PTSD criteria fulfilled before and after trauma
stabilisation treatment for all 365 clients
HTQ Number of participants McNemar test OR remission/risk
Pre-treatment Post-treatment Test statistica P
DSM-V PTSD
Intrusions 286 (78.4%) 75 (20.5%) 189.270 < 0.00001 20.18
Neg.Alt. cogn.&mood 273 (74.8%) 69 (18.9%) 189.032 < 0.00001 30.14
Arousal 285 (78.1%) 73 (20.0%) 202.368 < 0.00001 54
Avoidance 247 (67.7%) 66 (18.1%) 150.698 < 0.00001 11.65
ICD-11 PTSD
Re-experiencing 213 (58.4%) 49 (13.4%) 130.240 < 0.00001 9.2
Sense of threat 265 (72.6%) 69 (18.9%) 176.042 < 0.00001 20.6
Avoidance 247 (67.7%) 66 (18.1%) 150.698 < 0.00001 11.65
a Chi-Square, continuity corrected
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variance between DSM-V PTSD pre- and posttreatment is explained by the treatment. The
number needed to treat is 1.49. There was a significant effect of the group, indicating that the
remission of ICD-11 PTSD criteria differs between stabilisation treatment and control group,
F(1, 195) = 93.336, p < 0.00001, r = 0.569, ηp2 = 0.324. This indicates that 32.38% of the
variance between ICD-11 PTSD pre- and posttreatment is explained by the treatment. The
number needed to treat is 1.67. The differences in remission are highlighted in Figs. 8 and 9.
Discussion
Prevalence Rates
Prevalence of PTSD
To our knowledge, such a large group of clients with trauma-related disorders has never
been scrutinised so thoroughly anywhere in one of the three countries or in Southeast-
Asia as whole. There are very high levels of PTSD in this service-seeking group of the
clients. In the client group fulfilling all inclusion criteria (only stabilisation/
psychoeducation, no confrontation, pre-and post-treatment measures) the prevalence rate
of PTSD was 44.9% for ICD-11 PTSD (164 of 365 adults) and 54.0% for DSM-V PTSD
(197 of 356 adults). In the client group fulfilling all inclusion criteria except post-
diagnostic measures criteria (only stabilisation/ psychoeducation, no confrontation, pre-
treatment measure) the prevalence rate was 42.4% for ICD-11 PTSD (382 of 901 adults)
and 50.2% for DSM-V PTSD (452 of 901 adults). The prevalence of PTSD for all
service-seeking adults with pre-treatment measurement is 47.5% for ICD-11 PTSD (947
of 1993 adults) and 54.8% for DSM-V PTSD (1092 of 1993 adults).
Table 9 Remission of PTSD symptoms after trauma stabilisation treatment: Pairwise comparisons of the mean
number of fulfilled symptoms of the respective criterium for DSM-V/ICD-11 PTSD before and after trauma
stabilisation treatment for all 365 clients
HTQ Raw mean (standard deviation) t bootstrap p Hedges’s g ava
[BCa 95% CI]
r
Nr. Of symptoms Pre-treatment Post-treatment
DSM-V PTSD
Intrusionsb 2.12 (1.512) 0.41 (0.932) 19.203 < 0.001 1.56 [1.40, 1.73] 0.709
Neg.Alt. cogn.&moodc 3.59 (2.411) 0.73 (1.414) 20.873 < 0.001 1.44 [1.30, 1.60] 0.738
Arousald 3.145 (1.763) 0.72 (1.153) 24.489 < 0.001 1.63 [1.50, 1.76] 0.789
Avoidancee 1.16 (0.885) 0.24 (0.552) 17.356 < 0.001 1.25 [1.09, 1.39] 0.672
ICD-11 PTSD
Re-experiencingf 0.89 (0.843) 0.16 (0.445) 14.900 < 0.001 1.08 [0.93, 1.20] 0.615
Sense of threatf 1.17 (0.831) 0.24 (0.543) 18.723 < 0.001 1.32 [1.18, 1.45] 0.700
Avoidancee 1.16 (0.885) 0.24 (0.552) 17.356 < 0.001 1.24 [1.10, 1.38] 0.672
a Hedges’s g av is a corrected effect size to the biased Cohen’s dav
b 0–4 symptoms of DSM-V PTSD Intrusions possible
c 0–8 symptoms of DSM-V PTSD Neg.Alt. Cogn&Mood possible
d 0–5 symptoms of DSM-V PTSD Arousal possible
e 0–2 symptoms of DSM-V/ICD-11 PTSD Avoidance possible
f 0–2 symptoms of ICD-11 PTSD Re-experiencing/Sense of threat possible
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Prevalence of PTSD Syndrome Scales
The prevalence rates for the DSM-Vand ICD-11 Syndrome Scales of the client group fulfilling
all inclusion criteria (only stabilisation/psychoeducation, no confrontation, pre-post treatment
measures) were high, ranging between 58.4 and 78.4%. The difference between the diagnosis
via DSM-V and ICD-11 becomes apparent comparing the criteria, as 78.4% of the clients
fulfilled the DSM-V criterium Intrusions whereas only 58.4% fulfilled the respective ICD-11
criterium Re-experiencing.
Subclinical and Non-clinical Group of Clients
The way the data aggregation was set up – providing therapy and collecting diagnostic and
therapy data for all service-seeking clients without any screening for PTSD diagnosis before –
gives the opportunity to explore the whole range of trauma populations in Indonesia, Cambo-
dia and Thailand. Of the clients fulfilling all inclusion criteria, only 1.6% of the clients didn’t
fulfil any DSM-V PTSD criteria at all, 44.4% of the clients were subclinical for DSM-V
PTSD. For ICD-11 PTSD the prevalence is similar, only 1.6% of the clients didn’t fulfil any
ICD-11 criteria, 53.2% of the clients were subclinical for ICD-11 PTSD.
Effectiveness of Trauma Stabilisation Treatment
Remission Rates
This study demonstrates a treatment effect of Trauma Stabilization in significantly reducing
PTSD symptoms. Trauma Stabilisation treatment was associated with very high remission
rates for PTSD (91.4% for DSM V, 93.3% for ICD-11). The remission rates were also high for
all PTSD criteria (ranging between 72.1 and 86.0%). Thus, a symptom reduction was achieved
for all criteria, showing Trauma Stabilisation treatment was effective in reducing core PTSD
symptomatology - Intrusions/Re-experiencing, Arousal/Sense of threat, Neg.Alt.Cogn&mood
and Avoidance Behaviour. This study demonstrates that Trauma Stabilisation is a therapeutic
agent of change on the treatment of psychological trauma including PTSD.
Impact of Treatment on all Subgroups
The treatment effect impacted the whole range of post-traumatic stress symptoms. Subclinical
clients also improved following Trauma Stabilisation Intervention in addition to those diag-
nosed with PTSD and severe PTSD.
Even if subclinical and non-clinical PTSD clients were included in the analysis, results
suggest Trauma Stabilisation treatment still has a high treatment effect in reducing DSM-V
PTSD (Hedges’s gav = 1.62) and ICD-11 PTSD (Hedges’s gav = 1.39) as well as in reducing all
PTSD criteria (Hedges’s gav ranging between 1.08 and 1.63).
It is an advantage of the data aggregation of the Mekong I project that non-clinical and sub-
clinical groups can be included in the analysis. In contrast to clients fulfilling the PTSD
diagnoses pre-treatment, subclinical and non-clinical clients can get worse during the time of
the treatment, fulfilling the diagnosis after treatment. This important information can’t be given
in studies that screen for the diagnosis pre-treatment and only include clinical clients in the
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study. The rate of clients developing the diagnosis during treatment was low (1.4% of the
clients developed DSM-V PTSD, 2.7% of the clients developed ICD-11 PTSD.
When looking at the tables of remission of PTSD criteria (Tables 8 and 9), it should be
noted that a complete remission from all criteria is not possible for PTSD clients. There is no
possibility to remise from criterion A, thus, the rate of complete remission was 0%.
High Effect Sizes Regardless of Diagnostic System
Regardless of the diagnoses of PTSD via DSM-IV, DSM-V or ICD-11, a very high rate of
traumatized adults lost their diagnoses of PTSD after Trauma Stabilisation treatment. We can
report very high effect sizes for the treatment effect on the PTSD diagnosis via DSM-V
(Hedges’s g av = 3.08) or ICD-11 (Hedges’s g av = 3.78) as well as for the symptom reduction
all criteria (DSM Hedges’s gav between 2.50 and 3.09, ICD Hedges’s gav between 2.88 and
3.258). They emphasize the great benefit for traumatised populations of Trauma Stabilisation
Treatment. Nevertheless, the results from this study are extraordinarily high. Ferguson [44]
concludes that effect size interpretation, as demonstrated by the group differences pre and post
PTSD and different PTSD diagnostic criteria, indicate a strong effect (cut-off for strong effect:
Hedges g = 2.70). By means of explanation to account for this one aspect could relate to the
importance of the therapeutic relationship – which is also a potential agent of change. In fact
the Second Task Force on Evidence-Based Therapy Relationships convened by the American
Psychological Association consider this an integral factor [45]. They conclude - based on
meta-analyses and reviews, that the therapy relationship accounts to the treatment success at
least as much as the method/ paradigm used and thus should be explicitly addressed in practice
and treatment guidelines. This recommendation is met by the Trauma Stabilisation Interven-
tions as outlined in the ROTATE manual [34]. Norcross and Wampold [45] also describe that
an adaption of the therapy relationship to specific client characteristics (in addition to
diagnosis) enhanced the effectiveness of the treatment. One important aspect of adapting
psychotherapy to the individual client relates to culture. Common themes regarding cultural
adaptation include flexibility, adaptability, meaningfulness, empathy and traditional treatments
being used alongside existing resources [46]. In their meta-analysis Smith, Rodríguez [46]
show that culturally adapted mental health therapies are superior to therapies not incorporating
cultural considerations. Especially Asian American clients profited from culturally adapted
treatments compared to other American client groups. TheMekong Project I explicitly addressed
cultural considerations in their trainings, adaptions of stabilisation techniques to fit the cultural
background of the individual client were discussed and encouraged. Trauma Stabilisation
Treatments have the advantage of being flexible in their use and thus, give the therapist the
possibility to really adapt treatment interventions to the specific needs of their clients.
A further cultural consideration arose from the Mekong Project I therapists themselves
regarding the high treatment effect sizes this research highlights. Traditionally, Cambodian,
Thai and Indonesian clients don’t get any psychotherapeutic treatment at all. Thus, for all clients
the therapy connected to the Mekong I Project was their first psychological treatment. With
initial treatment interventions clients receive attention, validation of their trauma and posttrau-
matic stress problems. This is also an agent of change. Both components may contribute to a
desire of the client to please the therapist. The local therapists explained that this ‘wanting to
please’ also has a strong cultural component. It can’t be ruled out that at least some of the clients
wanted to please their therapists and show gratitude for the subsequent treatment they received.
Only further replication studies in other countries may either confirm or deny this hypothesis.
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Putting the Effect Sizes into Context
Mekong Project I considered whether the use of a waiting list control-group was feasible, but
this raised numerous ethical dilemmas and therefore was subsequently rejected. The Mekong I
Project was always set up as a trauma capacity building project to meet the needs of treatment
of a huge number of traumatised clients in South East Asia. Thus, the resources of the Project
were used to train as many therapists as possible, in as thorough and sustainable manner as was
possible. This included to offer trauma treatment to as many traumatized clients as possible –
namely in the form of EMDR Therapy. This limits the interpretation of the results, as Durlak
[47] emphasises effects for within-subject designs are usually much higher than for control
group designs and can easily exceed 1.0. Nevertheless, Devilly and McFarlane [48] describe
possibilities to still evaluate a study by comparison to existing data from wait-list controls. In
their meta-analysis, the unweighted average effect size of wait-list conditions was 0.358 with a
standard deviation of 0.276 and report clinical cut-offs to judge the relative efficacy of the
treatment. With the effect sizes above the treatment meta-analysis mean effect size 2.42 (DSM-
V Hedges’s g av = 3.078, BCa 95% CI [2.875, 3.271]; ICD-11 Hedges’s g av = 3.780, BCa 95%
CI [3.559, 3.994]), the trauma stabilisation treatment appears to be better than best practices for
PTSD treatment in the short term.
Nevertheless, the cultural context of the effect sizes isn’t taken into account in this
evaluation and Devilly and McFarlane [48] describe as an alternative approach to compare
the treatment group with the waiting-list group of a similar previous study. By comparing the
data to an intent to treat control group aggregated in the same time and region by the same
therapists with the same diagnostic tools, the waiting-list group of the RCT ROTATE [Trauma
Stabilisation] study [35, 36] is a very appropriate comparator. Additionally, the cultural
influences of the effect sizes are also present in this control group. The clients of this group
also didn’t have any treatment at all previously and get attention and validation of their trauma
for the first time. The only difference is that they get their free of charge treatments with a five-
week delay. Treatment expectancy effect and an understanding of one’s own presentation due
to structured assessment as well as feeling understood and supported [48], results in some
reduction in the severity pf PTSD symptoms in the short term. These aspects combined with
the cultural desire to please can explain the remission rate of 24.4% of DSM-V PTSD and
33.3% of ICD-11 PTSD after waiting. The effect sizes of these significant remissions are
medium (DSM-V PTSD Hedges’s g av = 0.594, ICD-11 PTSD Hedges’s g av = 0.761).
However, the effect sizes for trauma stabilisation are almost five times the size of being on a
waiting list. A direct comparison between the stabilisation treatment group and the waiting-list
group via general linear model analyses reveals a very large effect for the stabilisation
treatment. The explained variance between the groups is 31.03% for DSM-V PTSD and
32.38% of ICD-11 PTSD. Looking at the whole sample, regardless of the PTSD diagnosis
at first measurement, also a significant difference between the clients getting worse to the
second measurement becomes apparent. For the waiting-list groups five to six times more
clients get worse compared to the trauma stabilisation group (DSM-V PTSD 9.1% getting
worse during waiting, 1.4% getting worse during treatment, ICD-11 PTSD 14.6% getting
worse during waiting, 2.7% getting worse during treatment).
The results strengthen and corroborate the earlier findings of two RCTs that effective trauma
therapy can also significantly reduce posttraumatic symptoms without the need of trauma
exposure [35, 36, 49]. Nevertheless, with a comparison to a waiting list group non-specific
aspects of the treatment aren’t controlled. Further insights to the effectiveness of trauma
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stabilisation could be gained by treatment studies comparing trauma stabilisation treatment to a
control group receiving treatment as usual or comparing it to trauma confrontation interventions.
Criticism of Study
Nevertheless, the research and the results can be rightly criticized and viewed with a degree of
caution. Replication studies are much needed. A compromise had to be made between conveying
basic knowledge to the therapists and addressing the specific needs of the traumatised clients. With
the challenge of responding to victims’mental health needs in a post-disaster area and the priority
uponmental health capacity building through training, the ability tomeetmethodological quality of
the studies as inWestern samples is quite limited [14, 50]. Thus, limitations of our study are: (a) the
lack of a follow-up period (b) no external, blind rater of the PTSD-symptoms.Without a follow-up
measurement, no conclusions can be drawn to the sustainability of the treatment effect. But the
Mekong I Project as a capacity building project with the primary aim tomeet the needs of treatment
of a vast number of traumatised clients, would have been compromised by focusing at high study
standards as a follow-up measurement. A comparison to the remission rate of the ROTATE RCT
study where the assessments were performed by a blind to treatment allocation investigator (95.9%
PTSD remission, [36]) shows that the lack of a blind rater was of little consequence.
Advantages of the Study
Advantage of Local Therapists (Language, Culture)
A strength of our study is that the treatments taught in Mekong I were conducted by local
therapists who had been extensively trained and supervised in Trauma Stabilisation Interven-
tions. Consequently, Trauma Stabilisation has the benefit of being conducted using indigenous
language and therefore no interpreters were necessary. Additionally, the therapists and the
clients had similar cultural backgrounds, thus culture-specific interpretations of symptoms
could be considered, and techniques could be culturally adapted if necessary.
Uniform Training of all Therapist
All therapists were trained in trauma stabilisation during the trainings of the Mekong I
Project. They each had local clinical supervision which ensured treatment fidelity to the
trauma stabilisation interventions used. These were deemed as being consistent with high
levels of fidelity.
Generalizability to Real World Settings
Studies about the treatment of PTSD have been criticised for a vast number of exclusion
criteria for entrance into study which decreases the generalizability of a lot of results. PTSD is
associated with complex outcomes and multiple comorbid emotional, social and physical
health difficulties, particularly among those who have experienced chronic traumatisation,
but many published studies about Treatment Outcomes of PTSD exclude individuals with
severe comorbid psychopathology [51–53]. With the data of the Mekong Project the general-
izability to real world settings is extremely high, because for the clients in the Mekong Project
I, there were no exclusion criteria at all. Additionally, all clients were service seekers, people
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that were looking for therapy. Thus, the sample of the study is very generalizable to real world
settings, it consisted of clients that were looking for a trauma specific treatment.
As in real world settings, all service seeking clients received treatment and weren’t excluded
if a previously screened diagnosis wasn’t completely fulfilled. With the inclusion of all service
seeking clients regardless of their diagnosis, the results are not only more generalisable to real
world, but also important practical implications can be drawn. The analysis of how subclinical
clients develop under treatment gives important additional information about the range of the
treatment effect as well as potential risks of the specific treatment.
Trauma Stabilisation as Effective, Safe and Easy to Learn Therapy for Post Conflict
Areas
Especially in areas were mental health facilities are limited and the education of therapists low,
we see the need for an easy to learn and to culturally adapt treatment with no risks. Our results
strengthen earlier findings that trauma therapy doesn’t necessarily require trauma exposure to
be effective in reducing posttraumatic symptoms and increasing the level of functioning.
Trauma Stabilisation doesn’t focus on traumatic memories directly, but resource, stabilisation
and skill development. Especially in post conflict areas, with a high risk for natural disasters,
this treatment can prepare the clients for future traumatic events, strengthening coping skills
and enhancing resilience and potentially post-traumatic growth. A further advantage of
Trauma Stabilisation Interventions is that it can be taught to paraprofessionals and allied
health professionals in areas with a scarcity of mental health professionals. The results from
this study are promising but more research is needed to further explore the wider impact of
Trauma Stabilisation as a treatment effect in terms of clinical and economic benefits.
The study suggests that trauma stabilisation is safe, effective, efficient and sufficient in
treating clinical and subclinical trauma populations with the data indicating high remission
from PTSD and traumatic sequelae. Stabilisation techniques are adaptable, flexible, culturally
contextualised, spiritually sensitive and individually tailored to specific needs.
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